Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Trauner

Showing results (11-20 of 775) with videos related to

Pageof 78
Sort By:
Clinics in Liver Disease|February 5, 2008
Mechanisms of cholestasisGernot Zollner, Michael Trauner
Trends in Molecular Medicine|December 9, 2003
Molecular aspects of bile formation and cholestasisMarco Arrese, Michael Trauner
Annals of Hepatology|July 13, 2005
Transcriptional regulation of hepatobiliary transport systems in health and disease: implications for a rationale approach to the treatment of intrahepatic cholestasisMartin Wagner, Michael Trauner
British Journal of Pharmacology|January 13, 2009
Nuclear receptors as therapeutic targets in cholestatic liver diseasesGernot Zollner, Michael Trauner
Hepatology (Baltimore, Md.)|March 1, 2013
Adiponectin, bile acids, and burnt-out nonalcoholic steatohepatitis: new light on an old paradoxThierry Claudel, Michael Trauner
Journal of Hepatology|January 23, 2009
When lightning strikes twice: the plot thickens for a dual role of the anion exchanger 2 (AE2/SLC4A2) in the pathogenesis and treatment of primary biliary cirrhosisPeter Fickert, Michael Trauner
Wiener Medizinische Wochenschrift (1946)|August 29, 2006
Molecular mechanisms of cholestasisGernot Zollner, Michael Trauner
Gut|May 7, 2017
Chromosomal instability in HCC: a key function for checkpoint kinase 2Robert Eferl, Michael Trauner
Journal of Internal Medicine|July 7, 2022
Current treatment of non-alcoholic fatty liver diseaseRafael Paternostro, Michael Trauner
Expert Opinion on Drug Metabolism & Toxicology|March 29, 2012
Xenobiotic-induced liver injury and fibrosisChristoph H Österreicher, Michael Trauner
Pageof 78

Showing results (11-20 of 775) with videos related to

Sort By:
Pageof 78
Clinics in Liver Disease|February 5, 2008
Mechanisms of cholestasisGernot Zollner, Michael Trauner
Trends in Molecular Medicine|December 9, 2003
Molecular aspects of bile formation and cholestasisMarco Arrese, Michael Trauner
Annals of Hepatology|July 13, 2005
Transcriptional regulation of hepatobiliary transport systems in health and disease: implications for a rationale approach to the treatment of intrahepatic cholestasisMartin Wagner, Michael Trauner
British Journal of Pharmacology|January 13, 2009
Nuclear receptors as therapeutic targets in cholestatic liver diseasesGernot Zollner, Michael Trauner
Hepatology (Baltimore, Md.)|March 1, 2013
Adiponectin, bile acids, and burnt-out nonalcoholic steatohepatitis: new light on an old paradoxThierry Claudel, Michael Trauner
Journal of Hepatology|January 23, 2009
When lightning strikes twice: the plot thickens for a dual role of the anion exchanger 2 (AE2/SLC4A2) in the pathogenesis and treatment of primary biliary cirrhosisPeter Fickert, Michael Trauner
Wiener Medizinische Wochenschrift (1946)|August 29, 2006
Molecular mechanisms of cholestasisGernot Zollner, Michael Trauner
Gut|May 7, 2017
Chromosomal instability in HCC: a key function for checkpoint kinase 2Robert Eferl, Michael Trauner
Journal of Internal Medicine|July 7, 2022
Current treatment of non-alcoholic fatty liver diseaseRafael Paternostro, Michael Trauner
Expert Opinion on Drug Metabolism & Toxicology|March 29, 2012
Xenobiotic-induced liver injury and fibrosisChristoph H Österreicher, Michael Trauner
Pageof 78